MAPT and Alzheimer disease: Interestingly, Aβ did not have an effect on the mRNA expression of CDK5 or its regulators, p35 and p39, which are well-known candidate molecules responsible for the hyper-phosphorylation of tau protein in AD patients (Figure 5A).